Medication Adherence in Heart Failure After Hospitalisation

To explore medication adherence in patients who were hospitalised due to heart failure.

Completed

Looking for future studies?

Key information

Conditions

Adherence, Medication Behavior Cardiovascular Diseases Health Behavior Heart Diseases Heart Failure Medication Adherence Patient Acceptance of Health Care Patient Compliance Treatment Adherence and Compliance

Age range

118 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital Zurich

Zurich, 8090, Switzerland

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Diagnosis of Heart failure
Hospitalisation due to heart failure in the past two years

Exclusion criteria

Not speaking German
cognitive impairment

Treatment and study plan

Primary outcomes

Medication Adherence

Time frame: at one timepoint (cross sectional)

MARS-5 5-Item Medication Adherence Rating Scale

Sponsors and collaborators

Lead sponsor

University of Zurich

Other

Registry information

Official study title

Study Title Medikamentenadhärenz Bei Erwachsenen Personen Mit Herzinsuffizienz

Important dates

Study start: 2021
Primary completion: 2022
Study completion: 2022
First posted: Feb 10, 2022
Registry last updated: May 11, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed